NEW CLASS OF DRUGS: THERAPEUTIC RNAi INHIBITION OF PCSK9 AS A SPECIFIC LDL-C LOWERING THERAPY.

MLA

Strat, A. L., et al. “NEW CLASS OF DRUGS: THERAPEUTIC RNAi INHIBITION OF PCSK9 AS A SPECIFIC LDL-C LOWERING THERAPY.” Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi, vol. 120, no. 2, Apr. 2016, pp. 228–32. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=27483697&authtype=sso&custid=ns315887.

APA

Strat, A. L., Ghiciuc, C. M., Lupuşoru, C. E., & Mitu, F. (2016). NEW CLASS OF DRUGS: THERAPEUTIC RNAi INHIBITION OF PCSK9 AS A SPECIFIC LDL-C LOWERING THERAPY. Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi, 120(2), 228–232.

Chicago

Strat, A L, Cristina Mihaela Ghiciuc, Cătălina Elena Lupuşoru, and F Mitu. 2016. “NEW CLASS OF DRUGS: THERAPEUTIC RNAi INHIBITION OF PCSK9 AS A SPECIFIC LDL-C LOWERING THERAPY.” Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 120 (2): 228–32. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=27483697&authtype=sso&custid=ns315887.